For questions 98 to 104, match the toxin with the description. Each response may be
used once, more than once, or not at all.
A. binds to the ACh receptor
B. blocks reuptake of dopamine
C. blocks voltage-gated K+ channels
D. blocks voltage-gated Na+ channels
E. depletes norepinephrine (NE) from vesicles
F. inhibits GTP hydrolysis
G. prevents presynaptic release of quanta of ACh
B
For questions 98 to 104, match the toxin with the description. Each response may be
used once, more than once, or not at all.
A. binds to the ACh receptor
B. blocks reuptake of dopamine
C. blocks voltage-gated K+ channels
D. blocks voltage-gated Na+ channels
E. depletes norepinephrine (NE) from vesicles
F. inhibits GTP hydrolysis
G. prevents presynaptic release of quanta of ACh
E
For questions 98 to 104, match the toxin with the description. Each response may be
used once, more than once, or not at all.
A. binds to the ACh receptor
B. blocks reuptake of dopamine
C. blocks voltage-gated K+ channels
D. blocks voltage-gated Na+ channels
E. depletes norepinephrine (NE) from vesicles
F. inhibits GTP hydrolysis
G. prevents presynaptic release of quanta of ACh
C. blocks voltage-gated K+ channels
For questions 98 to 104, match the toxin with the description. Each response may be
used once, more than once, or not at all.
A. binds to the ACh receptor
B. blocks reuptake of dopamine
C. blocks voltage-gated K+ channels
D. blocks voltage-gated Na+ channels
E. depletes norepinephrine (NE) from vesicles
F. inhibits GTP hydrolysis
G. prevents presynaptic release of quanta of ACh
D
A
Hall p. 35. At the equilibrium potential, the chemical and electrical forces are
equal. There is no net movement of K ions across the membrane.
D
Hall p. 189. The py subunit inhibits activation by both stabilizing the binding
of GDP and inhibiting the binding of GTP.
C
G&G pp. 199-203. Succinylcholine and decamethonium cause depolarizing
neuromuscular blockade. The effect is not reversed by anticholinesterase
agents and is amplified by decreased muscle temperature.
For questions 108 to 111, match the area in the somatic sensory cortex with the
receptors. Each response may be used once, more than once, or not at all.
A. area 1
B. area 2
C. area 3a
D. area 3b
C
For questions 108-111 see K&S pp. 457-458.
For questions 108 to 111, match the area in the somatic sensory cortex with the
receptors. Each response may be used once, more than once, or not at all.
A. area 1
B. area 2
C. area 3a
D. area 3b
B
For questions 108 to 111, match the area in the somatic sensory cortex with the
receptors. Each response may be used once, more than once, or not at all.
A. area 1
B. area 2
C. area 3a
D. area 3b
D. area 3b
For questions 108 to 111, match the area in the somatic sensory cortex with the
receptors. Each response may be used once, more than once, or not at all.
A. area 1
B. area 2
C. area 3a
D. area 3b
A
A
K&S pp. 446-448. Proprioception from the leg is relayed in the lateral column
by axons of neurons in Clarke’s column. In addition to sending axons to the
primary somatic sensory cortex (St), thalamic neurons send a sparse projection
to the secondary somatic sensory cortex (SII).
For questions 113 to 121, match the region of the cerebellum with the clinical sign or
symptom. Each response may be used once, more than once, or not at all.
A. cerebellar hemisphere, intermediate part (interposed nuclei)
B. cerebellar hemisphere, lateral part (dentate nuclei)
C. flocculonodular (lateral vestibular nucleus)
D. vermis (fastigial nucleus)
E. none of the above
D
For questions 113-121 see K&S pp. 849-850.
For questions 113 to 121, match the region of the cerebellum with the clinical sign or
symptom. Each response may be used once, more than once, or not at all.
A. cerebellar hemisphere, intermediate part (interposed nuclei)
B. cerebellar hemisphere, lateral part (dentate nuclei)
C. flocculonodular (lateral vestibular nucleus)
D. vermis (fastigial nucleus)
E. none of the above
A
For questions 113 to 121, match the region of the cerebellum with the clinical sign or
symptom. Each response may be used once, more than once, or not at all.
A. cerebellar hemisphere, intermediate part (interposed nuclei)
B. cerebellar hemisphere, lateral part (dentate nuclei)
C. flocculonodular (lateral vestibular nucleus)
D. vermis (fastigial nucleus)
E. none of the above
B
For questions 113 to 121, match the region of the cerebellum with the clinical sign or
symptom. Each response may be used once, more than once, or not at all.
A. cerebellar hemisphere, intermediate part (interposed nuclei)
B. cerebellar hemisphere, lateral part (dentate nuclei)
C. flocculonodular (lateral vestibular nucleus)
D. vermis (fastigial nucleus)
E. none of the above
C
For questions 113 to 121, match the region of the cerebellum with the clinical sign or
symptom. Each response may be used once, more than once, or not at all.
A. cerebellar hemisphere, intermediate part (interposed nuclei)
B. cerebellar hemisphere, lateral part (dentate nuclei)
C. flocculonodular (lateral vestibular nucleus)
D. vermis (fastigial nucleus)
E. none of the above
D
For questions 113 to 121, match the region of the cerebellum with the clinical sign or
symptom. Each response may be used once, more than once, or not at all.
A. cerebellar hemisphere, intermediate part (interposed nuclei)
B. cerebellar hemisphere, lateral part (dentate nuclei)
C. flocculonodular (lateral vestibular nucleus)
D. vermis (fastigial nucleus)
E. none of the above
E
For questions 113 to 121, match the region of the cerebellum with the clinical sign or
symptom. Each response may be used once, more than once, or not at all.
A. cerebellar hemisphere, intermediate part (interposed nuclei)
B. cerebellar hemisphere, lateral part (dentate nuclei)
C. flocculonodular (lateral vestibular nucleus)
D. vermis (fastigial nucleus)
E. none of the above
D. vermis (fastigial nucleus)
For questions 113 to 121, match the region of the cerebellum with the clinical sign or
symptom. Each response may be used once, more than once, or not at all.
A. cerebellar hemisphere, intermediate part (interposed nuclei)
B. cerebellar hemisphere, lateral part (dentate nuclei)
C. flocculonodular (lateral vestibular nucleus)
D. vermis (fastigial nucleus)
E. none of the above
B
For questions 113 to 121, match the region of the cerebellum with the clinical sign or
symptom. Each response may be used once, more than once, or not at all.
A. cerebellar hemisphere, intermediate part (interposed nuclei)
B. cerebellar hemisphere, lateral part (dentate nuclei)
C. flocculonodular (lateral vestibular nucleus)
D. vermis (fastigial nucleus)
E. none of the above
B
A
G&G p. 911. Nitric oxide production in neurons is from L-arginine by nitric oxide
synthetase acting in conjunction with the cofactor, reduced nicotinamide
adenine dinucleotide phosphate (NADPH), and Ca2+ ions. The arginine is
converted to citrulline.G&G p. 911. Nitric oxide production in neurons is from L-arginine by nitric oxide
synthetase acting in conjunction with the cofactor, reduced nicotinamide
adenine dinucleotide phosphate (NADPH), and Ca2+ ions. The arginine is
converted to citrulline.
E
Carp p. 253. The pineal gland synthesizes melatonin from serotonin by the
action of two enzymes sensitive to variations of diurnal light. The rhythmic
fluctuations in melatonin synthesis are directly related to the daily light cycle.
For questions 124 to 128, match the receptor with the description. Each response may
be used once, more than once, or not at all.
A. muscarinic receptor
B. nicotinic receptor
C. .
D. neither
C. both
For questions 124-128 see K&S pp. 187-189, 241-242. The nicotinic and
muscarinic receptors both bind acetylcholine and are found in sympathetic
neurons, whereas the directly gated receptors in skeletal muscle are muscarinic.
Hexamethonium selectively blocks nicotinic ACh receptors. Muscarinic receptors
activate a second messenger system that closes a K+ channel (called the
M channel).